Maltofer Syrup Special Precautions

Anaemias should always be treated under the supervision of a doctor. If therapeutic success (increase in haemoglobin by about 2-3 g/dL after 3 weeks) is not achieved, treatment should be reconsidered.
Infections or tumours may cause anaemia. Since iron can be utilised only after correcting the primary disease, a benefit/risk evaluation is advisable.
During treatment with Maltofer, there may be dark discolouration of the faeces (stools); however this is of no clinical relevance.
1 mL of Maltofer syrup contains 1 mg of sodium. This corresponds to 0.05% of the WHO-recommended maximum daily intake of 2 g of sodium for adults.
1 mL Maltofer syrup contains 0.28 mg of sorbitol. Sorbitol can cause gastrointestinal disorders and has a slight laxative effect. Patients with hereditary fructose intolerance (HFI) should not take/receive this medicinal product.
1 mL of Maltofer syrup contains 200 mg of sucrose. Diabetes patients must take this into account. Sucrose can be harmful to the teeth.
Maltofer syrup contains small quantities of ethanol (alcohol) of less than 100 mg per 30 mL (maximum daily dose).
Maltofer syrup contains methyl hydroxybenzoate (E218) and propyl hydroxybenzoate (E216). These can cause allergic reactions, even delayed reactions.
Effects on ability to drive and use machines: No relevant studies have been performed. However, it is unlikely that Maltofer has any effect on the ability to drive and use machines.